Showing results (901-910 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|October 18, 2018
GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetesFelix Aberer, Katharina M Lichtenegger, Edin Smajic, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trialMegumi Inoue, Martin Lorenz, Hideya Muto, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetesRegitse H Christensen, Christian S Hansen, Bernt Johan von Scholten, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trialChristian Anholm, Preman Kumarathurai, Amirsalar Samkani, et al.
Diabetes, Obesity & Metabolism|February 7, 2022
Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanismsM Ghidewon, H S Wald, A D McKnight, et al.
Diabetes, Obesity & Metabolism|October 18, 2021
Vagal afferent cholecystokinin receptor activation is required for glucagon-like peptide-1-induced satiationVasiliki Vana, Michelle K Laerke, Jens F Rehfeld, et al.
Diabetes, Obesity & Metabolism|February 3, 2022
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrologySimke W Waijer, Michele Provenzano, Skander Mulder, et al.
Diabetes, Obesity & Metabolism|April 18, 2022
Positive allosteric γ-aminobutyric acid type A receptor modulation prevents lipotoxicity-induced injury in hepatocytes in vitroElisabeth Rohbeck, Birgit Hasse, Guido Koopmans, et al.
Diabetes, Obesity & Metabolism|September 5, 2018
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control studyAndrea Natali, Lorenzo Nesti, Elena Venturi, et al.
Diabetes, Obesity & Metabolism|September 28, 2018
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trialJohn B Buse, Anders L Carlson, Mitsuhisa Komatsu, et al.
Pageof 632